Epratuzumab (Anti-Siglec-2 / CD22)
Epratuzumab (Anti-Siglec-2 / CD22) (A3056-GRP)
Products
Description
Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A3056 |